![]() MolMed MolMed is a biotechnology company focused on research, development and clinical validation of novel antitumour therapies. | ![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ![]() BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer. | |
Founding Date | Founding Date 1996 | Founding Date 2015 | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Milano, IT HQ Bresso, IT | Locations South San Francisco, US HQ | Locations San Diego, US HQ |
Employees | Employees 186 | Employees 64 | Employees 616% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) 100.8 m |
Financial | |||
Net income | Net income (€427k) (FY, 2019) | Net income ($129.9m) (FY, 2024) | Net income ($59.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 176m | Total funding raised $ 186.5m |

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
View company